By 2024, Ozempic had surpassed Trulicity, also approved for type 2 diabetes (not obesity) to make up the largest share of GLP-1 prescriptions and spending (39% in 2024)
Back Mojsov, S, Weir, GC, Habener, JF (Feb 1987) 'Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas', Journal of Clinical Investigation , 79, 616-19
injectable semaglutide: side effects and risks Semaglutide tablets and injections share many similar side effects, since they both contain semaglutide as the active ingredient
Dietary changes : Patients starting GLP-1 therapy often make significant dietary modifications, including increased vegetable and fruit consumption (which have high water content) and reduced processed food intake
Patients currently using compounded semaglutide or tirzepatide should discuss alternatives with their prescriber